Navigation Links
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
Date:9/25/2008

yCommitment.org, an online portal where anybody can make their own Commitment to Action.

For more details on CGI and the 2008 Annual Meeting, please visit http://www.clintonglobalinitiative.org or contact press@clintonglobalinitiative.org.

This announcement contains forward-looking statements relating to Napo Pharmaceuticals and its products that involve risks and uncertainties, including statements regarding future products and developments that are not historical facts. Such statements are only predictions and the company's actual results may differ materially from those anticipated in these forward-looking statements. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should,'' "could," "project," "plan,'' "seek," "intend,'' or "anticipate'' or the negative thereof or comparable terminology and statements about industry trends and Napo's future performance, operations and products.


'/>"/>
SOURCE Napo Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
2. DFB Sells Coria Labs to Valeant Pharmaceuticals
3. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
4. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
5. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
6. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
7. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
8. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
9. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
11. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... N.J., Dec. 17 Osteotech, Inc. (Nasdaq: ... field of biologic products for regenerative healing, announced ... to the United States Food and Drug Administration ... of its Duratech(TM) BioRegeneration Matrix to repair or ... the brain) in various cranial surgical procedures. ...
(Date:12/17/2009)... Institute,s Top 10 Health Industry Issues in 2010, puts healthcare cost ... for the year ahead. , ... New York, ... Top 10 Health Industry Issues in 2010, puts ... the overarching theme for the year ahead. , , , , ...
(Date:12/17/2009)... the Rx Club, the Daveys, the GLOBALS, ,and PM360 Pharma ... ... December 17, 2009 -- Chicago-based full-service healthcare communications agency Goble ... marketing awards programs honoring exceptional creative and interactive work. , ... G&A with 9 Awards of Excellence for the following creative ...
(Date:12/16/2009)... historians, journalists and politicians, and has been recounted everywhere ... Congress: British forces used chemical weapons on Iraqis just ... has never been fully squared with the historical record, ... According to Douglas,s research, forthcoming in the December issue ... such incident ever occurred. , Allegations of chemical ...
Breaking Biology Technology:Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4
... will release its third quarter 2007 financial results on ... will be available,on the PPD Web site at ... October 24, at 9 a.m. ET, PPD will conduct ... results and the,overall business environment. A Q&A session will ...
... LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies ... report its,financial results for the fiscal year ended ... improved its productivity and operational,profitability while continuing its ... Asian markets, resulting in,sustainable sales growth. Financial ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced ... a U.K. Phase Ia/Ib combination,REOLYSIN(R) and radiation ... cancers is scheduled to be presented at ... October 2, 2007 in Birmingham, U.K.,The presentation, ...
Other Biology Technology:PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... IgeaCare Solutions Inc. is pleased to ... healthcare communications company previously operating as IgeaCare Systems ... move forward under new leadership and funding. ,, ... to the position of Chief Executive Officer. Under ... providing a superior servicing and support model; fast ...
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 1Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 3MD On Line Inc Acquires Medical Claim Corp 47920 1MD On Line Inc Acquires Medical Claim Corp 47920 2Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 2
... A new study has found that large segments of ... phytoplankton growth and the absence of the mineral stresses ... pigments that make ocean productivity appear more robust than ... of satellite chlorophyll data may be inaccurate, the researchers ...
... relatively benign compound contained in a widely used group ... of existing pesticides in the environment, according to a ... California, Berkeley. , While the increase in toxicity was ... were unexpected, the researchers said. , The study's results, ...
... researchers has created technology to regrow teeth--the first time ... , Using low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy ... Jie Chen and Dr. Ying Tsui from the Faculty ... a non-invasive and novel way to stimulate jaw growth ...
Other Biology News:Iron critical to ocean productivity, carbon uptake 2Iron critical to ocean productivity, carbon uptake 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Ultrasound may help regrow teeth 2